General Comments, page-42

Underwhelmed by capital raising (no participation offered to retail investors) and today's presentation.
It recapped of how good the technology is, which they keep telling us. It's the reason I'm an investor, but there is nothing to demonstrate it is capable of achieving market traction! it has been available to clinicians, schools and directly to parents for well over 12 months but no credible sales. And the "Near term milestones " makes no reference to achieving any sales target. If the company is unable to get any meaningful sales in its home market, how will it go overseas?
The implication in the presentation is Tali Detect will be the saviour to secure Tali Train uptake. Hmmm, are management saying "look this way" to deflect attention from its inability to make sales from Tali Train.
I remain optimistic, and holding, but not confident the ghost of Avexa is still haunting this company.
The next six months will be critical.!